MacroGenics Historical Balance Sheet

MGNX Stock

USD 2.00 0.10 4.76%

Trend analysis of MacroGenics balance sheet accounts such as Total Stockholder Equity of 194.5 M provides information on MacroGenics' total assets, liabilities, and equity, which is the actual value of MacroGenics to its prevalent stockholders. By breaking down trends over time using MacroGenics balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining MacroGenics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether MacroGenics is a good buy for the upcoming year.

MacroGenics Inventory

1.22 Million

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MacroGenics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy MacroGenics Stock please use our How to Invest in MacroGenics guide.

About MacroGenics Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of MacroGenics at a specified time, usually calculated after every quarter, six months, or one year. MacroGenics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of MacroGenics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which MacroGenics currently owns. An asset can also be divided into two categories, current and non-current.

MacroGenics Balance Sheet Chart

At this time, MacroGenics' Total Current Assets are fairly stable compared to the past year. Accumulated Other Comprehensive Income is likely to rise to 4,200 in 2025, whereas Total Current Liabilities is likely to drop slightly above 48.8 M in 2025.

Total Assets Total Current Liabilities Other Liab Property Plant And Equipment Net Cash

Add Fundamental

Total Assets

Total assets refers to the total amount of MacroGenics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in MacroGenics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on MacroGenics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of MacroGenics are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Property Plant And Equipment Net

The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.

Cash

Cash refers to the most liquid asset of MacroGenics, which is listed under current asset account on MacroGenics balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from MacroGenics customers. The amounts must be unrestricted with restricted cash listed in a different MacroGenics account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.

Most accounts from MacroGenics' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into MacroGenics current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MacroGenics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy MacroGenics Stock please use our How to Invest in MacroGenics guide.At this time, MacroGenics' Total Current Assets are fairly stable compared to the past year. Accumulated Other Comprehensive Income is likely to rise to 4,200 in 2025, whereas Total Current Liabilities is likely to drop slightly above 48.8 M in 2025.

	2022	2023	2024	2025 (projected)
Cash	108.9M	101.0M	182.8M	150.3M
Accounts Payable	4.9M	6.4M	5.0M	6.1M

Cash Accounts Payable

MacroGenics balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Common Stock
Total Assets		0.31	0.37	0.96	-0.2	0.77	-0.33	-0.61	-0.49	-0.13	0.73	0.8	0.4	0.22	0.95	0.37	0.78	0.7	0.09	0.52	0.71	0.2	0.48	0.99	-0.28	0.8
Other Current Liab	0.31		0.31	0.22	0.17	0.33	0.0	-0.03	-0.28	0.19	0.09	0.33	0.12	0.08	0.25	0.18	0.17	0.49	0.24	0.2	0.31	0.31	0.26	0.29	-1.0	0.18
Total Current Liabilities	0.37	0.31		0.17	0.1	0.68	0.22	-0.08	-0.68	0.61	0.21	0.68	0.35	0.57	0.16	0.39	0.56	0.68	0.36	0.67	0.68	0.7	0.7	0.27	-0.29	0.56
Total Stockholder Equity	0.96	0.22	0.17		-0.4	0.59	-0.48	-0.67	-0.25	-0.21	0.72	0.66	0.44	0.2	0.97	0.23	0.6	0.48	-0.16	0.44	0.5	-0.09	0.28	0.97	-0.2	0.64
Other Liab	-0.2	0.17	0.1	-0.4		0.17	0.55	0.16	-0.44	-0.14	-0.12	-0.07	-0.7	-0.45	-0.27	0.22	0.1	0.23	0.87	-0.37	0.21	0.66	0.37	-0.22	-0.17	0.09
Property Plant And Equipment Net	0.77	0.33	0.68	0.59	0.17		0.13	-0.39	-0.72	-0.05	0.56	0.95	0.28	0.13	0.55	0.69	0.82	0.83	0.44	0.46	0.83	0.65	0.6	0.67	-0.3	0.83
Current Deferred Revenue	-0.33	0.0	0.22	-0.48	0.55	0.13		0.45	-0.29	0.24	-0.39	0.01	-0.44	-0.02	-0.54	0.66	0.0	0.14	0.49	-0.05	0.14	0.51	-0.08	-0.39	-0.01	0.01
Net Debt	-0.61	-0.03	-0.08	-0.67	0.16	-0.39	0.45		0.0	0.43	-0.96	-0.34	-0.13	0.08	-0.66	-0.09	-0.3	-0.12	0.14	-0.07	-0.15	0.15	-0.18	-0.64	0.01	-0.3
Retained Earnings	-0.49	-0.28	-0.68	-0.25	-0.44	-0.72	-0.29	0.0		-0.24	-0.21	-0.68	-0.15	-0.27	-0.29	-0.43	-0.84	-0.9	-0.8	-0.59	-0.92	-0.85	-0.86	-0.41	0.26	-0.84
Accounts Payable	-0.13	0.19	0.61	-0.21	-0.14	-0.05	0.24	0.43	-0.24		-0.38	0.05	0.31	0.69	-0.22	-0.03	0.0	0.18	0.01	0.57	0.17	0.26	0.23	-0.18	-0.19	0.0
Cash	0.73	0.09	0.21	0.72	-0.12	0.56	-0.39	-0.96	-0.21	-0.38		0.52	0.23	-0.02	0.72	0.21	0.53	0.35	-0.01	0.23	0.38	0.05	0.31	0.74	-0.07	0.52
Non Current Assets Total	0.8	0.33	0.68	0.66	-0.07	0.95	0.01	-0.34	-0.68	0.05	0.52		0.54	0.24	0.58	0.62	0.81	0.82	0.29	0.62	0.82	0.52	0.56	0.7	-0.3	0.83
Non Currrent Assets Other	0.4	0.12	0.35	0.44	-0.7	0.28	-0.44	-0.13	-0.15	0.31	0.23	0.54		0.43	0.32	-0.02	0.31	0.29	-0.32	0.69	0.29	-0.09	0.16	0.34	-0.11	0.32
Other Assets	0.22	0.08	0.57	0.2	-0.45	0.13	-0.02	0.08	-0.27	0.69	-0.02	0.24	0.43		0.16	0.0	0.29	0.33	-0.22	0.76	0.34	0.08	0.31	0.2	-0.07	0.31
Cash And Short Term Investments	0.95	0.25	0.16	0.97	-0.27	0.55	-0.54	-0.66	-0.29	-0.22	0.72	0.58	0.32	0.16		0.11	0.63	0.52	-0.06	0.38	0.53	-0.01	0.39	0.98	-0.23	0.65
Net Receivables	0.37	0.18	0.39	0.23	0.22	0.69	0.66	-0.09	-0.43	-0.03	0.21	0.62	-0.02	0.0	0.11		0.47	0.51	0.31	0.26	0.51	0.49	0.03	0.28	-0.16	0.49
Common Stock Total Equity	0.78	0.17	0.56	0.6	0.1	0.82	0.0	-0.3	-0.84	0.0	0.53	0.81	0.31	0.29	0.63	0.47		0.92	0.47	0.63	0.96	0.64	0.7	0.72	-0.14	0.99
Common Stock Shares Outstanding	0.7	0.49	0.68	0.48	0.23	0.83	0.14	-0.12	-0.9	0.18	0.35	0.82	0.29	0.33	0.52	0.51	0.92		0.59	0.65	0.98	0.77	0.75	0.62	-0.47	0.92
Non Current Liabilities Total	0.09	0.24	0.36	-0.16	0.87	0.44	0.49	0.14	-0.8	0.01	-0.01	0.29	-0.32	-0.22	-0.06	0.31	0.47	0.59		0.04	0.58	0.84	0.66	0.03	-0.23	0.47
Other Current Assets	0.52	0.2	0.67	0.44	-0.37	0.46	-0.05	-0.07	-0.59	0.57	0.23	0.62	0.69	0.76	0.38	0.26	0.63	0.65	0.04		0.68	0.31	0.49	0.46	-0.18	0.65
Other Stockholder Equity	0.71	0.31	0.68	0.5	0.21	0.83	0.14	-0.15	-0.92	0.17	0.38	0.82	0.29	0.34	0.53	0.51	0.96	0.98	0.58	0.68		0.76	0.76	0.64	-0.28	0.96
Total Liab	0.2	0.31	0.7	-0.09	0.66	0.65	0.51	0.15	-0.85	0.26	0.05	0.52	-0.09	0.08	-0.01	0.49	0.64	0.77	0.84	0.31	0.76		0.7	0.11	-0.3	0.61
Property Plant And Equipment Gross	0.48	0.26	0.7	0.28	0.37	0.6	-0.08	-0.18	-0.86	0.23	0.31	0.56	0.16	0.31	0.39	0.03	0.7	0.75	0.66	0.49	0.76	0.7		0.43	-0.23	0.71
Total Current Assets	0.99	0.29	0.27	0.97	-0.22	0.67	-0.39	-0.64	-0.41	-0.18	0.74	0.7	0.34	0.2	0.98	0.28	0.72	0.62	0.03	0.46	0.64	0.11	0.43		-0.26	0.75
Short Term Debt	-0.28	-1.0	-0.29	-0.2	-0.17	-0.3	-0.01	0.01	0.26	-0.19	-0.07	-0.3	-0.11	-0.07	-0.23	-0.16	-0.14	-0.47	-0.23	-0.18	-0.28	-0.3	-0.23	-0.26		-0.14
Common Stock	0.8	0.18	0.56	0.64	0.09	0.83	0.01	-0.3	-0.84	0.0	0.52	0.83	0.32	0.31	0.65	0.49	0.99	0.92	0.47	0.65	0.96	0.61	0.71	0.75	-0.14

Click cells to compare fundamentals

MacroGenics Account Relationship Matchups

MacroGenics balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	378.7M	335.2M	280.5M	298.4M	261.7M	287.5M
Other Current Liab	26.2M	24.4M	19.5M	24.2M	29.3M	30.8M
Total Current Liabilities	50.7M	74.6M	48.6M	56.1M	55.5M	48.8M
Total Stockholder Equity	295.9M	239.6M	142.0M	152.6M	116.1M	194.5M
Other Liab	9.2M	6.9M	258K	59.7M	53.8M	56.5M
Property Plant And Equipment Net	42.2M	37.7M	56.9M	45.7M	42.6M	33.9M
Current Deferred Revenue	11.4M	20.6M	69.5M	21.7M	16.3M	22.0M
Net Debt	(151.9M)	(98.0M)	(74.1M)	(67.0M)	(145.4M)	(152.6M)
Retained Earnings	(771.8M)	(973.9M)	(1.1B)	(1.1B)	(1.2B)	(1.1B)
Accounts Payable	8.0M	15.5M	4.9M	6.4M	5.0M	6.1M
Cash	181.1M	123.5M	108.9M	101.0M	182.8M	150.3M
Non Current Assets Total	66.1M	55.7M	58.3M	47.1M	44.2M	41.3M
Non Currrent Assets Other	23.9M	18.0M	(7.7M)	1.4M	1.6M	1.5M
Other Assets	23.9M	335.2M	1.4M	1.0	1.15	1.09
Cash And Short Term Investments	272.5M	243.6M	154.3M	229.8M	201.7M	224.5M
Net Receivables	23.1M	10.4M	56.2M	10.4M	4.3M	4.1M
Common Stock Total Equity	490K	562K	613K	617K	709.6K	396.0K
Common Stock Shares Outstanding	52.4M	59.9M	61.4M	61.9M	62.6M	44.0M
Liabilities And Stockholders Equity	378.7M	335.2M	280.5M	298.4M	261.7M	287.5M
Non Current Liabilities Total	32.2M	21.0M	89.8M	89.7M	90.1M	94.6M
Other Current Assets	34.0M	42.3M	10.2M	9.9M	11.5M	11.1M
Other Stockholder Equity	1.1B	1.2B	1.2B	1.3B	1.3B	819.7M
Total Liab	82.9M	95.6M	138.5M	145.8M	145.6M	93.0M
Property Plant And Equipment Gross	42.2M	110.5M	29.6M	134.1M	131.3M	137.9M
Total Current Assets	312.6M	279.6M	222.2M	251.3M	217.5M	246.2M
Accumulated Other Comprehensive Income	(3K)	16K	(7K)	(6K)	4K	4.2K
Short Term Debt	8.0M	9.4M	9.5M	3.8M	4.9M	4.6M
Common Stock	562K	613K	617K	621K	628K	437.6K
Property Plant Equipment	68.4M	42.2M	37.7M	29.6M	34.0M	30.8M
Short Long Term Debt Total	29.2M	25.5M	34.8M	34.0M	37.5M	20.8M
Net Tangible Assets	230.6M	295.9M	239.6M	142.0M	163.3M	245.6M
Short Term Investments	91.4M	120.1M	45.5M	128.8M	18.8M	17.9M
Capital Surpluse	872.2M	1.1B	1.2B	1.2B	1.4B	817.2M
Net Invested Capital	295.9M	239.6M	142.0M	152.6M	116.1M	171.9M
Net Working Capital	261.9M	205.0M	173.6M	195.2M	162.0M	167.4M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

Additional Tools for MacroGenics Stock Analysis

When running MacroGenics' price analysis, check to measure MacroGenics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MacroGenics is operating at the current time. Most of MacroGenics' value examination focuses on studying past and present price action to predict the probability of MacroGenics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MacroGenics' price. Additionally, you may evaluate how the addition of MacroGenics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

MacroGenics Historical Balance Sheet

MacroGenics Inventory

1.22 Million

About MacroGenics Balance Sheet Analysis

MacroGenics Balance Sheet Chart

Total Assets

Total Current Liabilities

Property Plant And Equipment Net

Cash

MacroGenics balance sheet Correlations

MacroGenics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

MacroGenics balance sheet Accounts

Also Currently Popular

Additional Tools for MacroGenics Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 0.99	Total Assets
Common Stock	+ 0.99	Common Stock Total Equity
Total Current Assets	+ 0.98	Cash And Short Term Investments
Other Stockholder Equity	+ 0.98	Common Stock Shares Outstanding
Cash And Short Term Investments	+ 0.97	Total Stockholder Equity
Total Current Assets	+ 0.97	Total Stockholder Equity

Short Term Debt	- 1.0	Other Current Liab
Cash	- 0.96	Net Debt
Other Stockholder Equity	- 0.92	Retained Earnings
Common Stock Shares Outstanding	- 0.9	Retained Earnings
Property Plant And Equipment Gross	- 0.86	Retained Earnings
Total Liab	- 0.85	Retained Earnings